Nancy Wysenski Insider Trading $CYTK CYTOKINETICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy Wysenski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Wysenski. Nancy Wysenski is Director in NORTH AMERICAN SCIENTIFIC INC ($NASI) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in CYTOKINETICS INC ($CYTK) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in Alkermes plc. ($ALKS) and Director in Dova Pharmaceuticals, Inc. ($DOVA) and Director in Provention Bio, Inc. ($PRVB).
Nancy Wysenski in CYTOKINETICS INC
Trading Symbol: CYTKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Wysenski: Director
Holdings: 5,459 shares
Current Value: $63,870
Latest Transaction: May 13 2021
$CYTK Market Capitalization: $461.88M
$CYTK Previous Close: $11.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nancy Wysenski in CYTOKINETICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALKS, CYTK, DOVA, GEB, NASI, PRVB, TTPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | CYTK | CYTOKINETICS INC | Wysenski Nancy | Director | Option Exercise | A | 24.32 | 10,000 | 243,200 | 10,000 | |
May 13 2021 | CYTK | CYTOKINETICS INC | Wysenski Nancy | Director | Grant | A | 0.00 | 5,000 | 0 | 5,459 | 459 to 5.5 K (+1,089.32 %) |
Apr 05 2021 | CYTK | CYTOKINETICS INC | Wysenski Nancy | Director | Grant | A | 24.44 | 204 | 4,986 | 459 | 255 to 459 (+80.00 %) |
Page: 1